Table 1.
Characteristics of study group. ABCB1 analysis group was involved in the ABCB1 gene expression and methylation analysis, while TLDA analysis group was profiled for the ABC transporter genes expression. NPT – noncancerous prostate tissue; PCa – prostate cancer; BCR – biochemical recurrence; PSA – prostate-specific antigen
Variable | ABCB1 analysis group | TLDA analysis group | ||
---|---|---|---|---|
N = 93 | N = 16 | |||
NPT | PCa | NPT | PCa | |
N = 15 + 10a | N = 78 | N = 6 | N = 10 | |
Mean age in years ± SEM | 62.13 ± 1.01 | 60.76 ± 0.85 | 61.33 ± 1.09 | 62.9 ± 2.04 |
Pathological stage | ||||
pT2 | 52 | 5 | ||
pT3 | 25 | 5 | ||
Gleason score | ||||
6 | 18 | 3 | ||
≥ 7 | 54 | 7 | ||
Unknown | 1 | |||
BCR | ||||
Yes | 20 | 5 | ||
No | 53 | 5 | ||
Unknown | 5 | |||
TMPRSS2-ERG status | ||||
Positive | 51 | 6 | ||
Negative | 27 | 4 | ||
Mean PSA level at diagnosis, ng/ml ± SEM | 10.57 ± 1.25 | 11.07 ± 3.03 | ||
Methylation status of ABCB1 promoter | ||||
Methylated | 4 | 56 | 5 | |
Unmethylated | 15 | 22 | 5 | |
Unknown | 6 | 6 | ||
Mean expression of ABCB1, ∆Cq ± SEM | 7.50 ± 0.24 | 8.14 ± 0.13 | 5.01 ± 0.18 | 5.61 ± 0.17 |
aTen additional samples were included in ABCB1 methylation analysis